1. Home
  2. DARE vs NTZ Comparison

DARE vs NTZ Comparison

Compare DARE & NTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DARE
  • NTZ
  • Stock Information
  • Founded
  • DARE 2015
  • NTZ 1959
  • Country
  • DARE United States
  • NTZ Italy
  • Employees
  • DARE N/A
  • NTZ N/A
  • Industry
  • DARE Biotechnology: Pharmaceutical Preparations
  • NTZ Home Furnishings
  • Sector
  • DARE Health Care
  • NTZ Consumer Discretionary
  • Exchange
  • DARE Nasdaq
  • NTZ Nasdaq
  • Market Cap
  • DARE 28.0M
  • NTZ 31.2M
  • IPO Year
  • DARE N/A
  • NTZ 1993
  • Fundamental
  • Price
  • DARE $2.10
  • NTZ $3.80
  • Analyst Decision
  • DARE Strong Buy
  • NTZ
  • Analyst Count
  • DARE 2
  • NTZ 0
  • Target Price
  • DARE $10.00
  • NTZ N/A
  • AVG Volume (30 Days)
  • DARE 124.8K
  • NTZ 3.5K
  • Earning Date
  • DARE 11-13-2025
  • NTZ 10-21-2025
  • Dividend Yield
  • DARE N/A
  • NTZ N/A
  • EPS Growth
  • DARE N/A
  • NTZ N/A
  • EPS
  • DARE N/A
  • NTZ N/A
  • Revenue
  • DARE N/A
  • NTZ $337,653,480.00
  • Revenue This Year
  • DARE $6,864.02
  • NTZ N/A
  • Revenue Next Year
  • DARE $4,922.46
  • NTZ N/A
  • P/E Ratio
  • DARE N/A
  • NTZ N/A
  • Revenue Growth
  • DARE N/A
  • NTZ N/A
  • 52 Week Low
  • DARE $1.83
  • NTZ $2.15
  • 52 Week High
  • DARE $9.19
  • NTZ $6.27
  • Technical
  • Relative Strength Index (RSI)
  • DARE 51.03
  • NTZ 67.51
  • Support Level
  • DARE N/A
  • NTZ $2.94
  • Resistance Level
  • DARE $2.15
  • NTZ $3.50
  • Average True Range (ATR)
  • DARE 0.07
  • NTZ 0.13
  • MACD
  • DARE -0.06
  • NTZ 0.08
  • Stochastic Oscillator
  • DARE 95.53
  • NTZ 79.84

About DARE Dare Bioscience Inc.

Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.

About NTZ Natuzzi S.p.A.

Natuzzi SpA is an Italian firm that designs, manufactures, and sells contemporary and traditional leather and fabric-upholstered furniture. Its product portfolio includes sofas, loveseats, armchairs, sectional furniture, motion furniture and sofa beds, living room furnishings, and accessories. The company markets its products under several brands such as Natuzzi Italia, Private label, and Natuzzi Editions. Geographically, it derives a majority of its revenue from the United States of America and also has an international presence in Italy, Spain, the UK, China, and Other countries.

Share on Social Networks: